Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the renal denervation devices market grown over the years?

The market size of renal denervation devices has seen significant expansion in the previous years, with a projected growth from $0.55 billion in 2024 to $0.74 billion in 2025, marking a compound annual growth rate (CAGR) of 34.0%. This past growth surge can be linked to a rise in hypertension cases, advancements in clinical research and studies, an increase in cardiovascular diseases, initial approval from the FDA, regulatory developments, and the introduction of renal denervation systems in the market.

What Is the forecasted market size and growth rate for the renal denervation devices market?

In the upcoming years, the market size for renal denervation devices is anticipated to witness substantial growth, reaching “$2.28 billion by 2029 with a CAGR of 32.3%. The growth over the forecasted period can be credited to a patient-oriented approach, enhancement of healthcare infrastructure, increasing knowledge and acceptance, emphasis on minimally invasive treatments, and the introduction of new devices in the market. Key trends for the same period involve the incorporation of AI and machine learning, changes in regulatory landscape, inclination towards minimally invasive procedures, focus on clinical evidence, and the combination of remote monitoring and telehealth.

Get your renal denervation devices market report here!

https://www.thebusinessresearchcompany.com/report/renal-denervation-devices-global-market-report

What are the major factors driving growth in the renal denervation devices market?

The amplifying occurrence of hypertension is anticipated to stimulate the expansion of the renal denervation devices market. Hypertension or high blood pressure is a condition marked by an unvarying excessive force of blood coursing through the blood vessels. Renal denervation, a catheter-dependent procedure, has emerged as a potential treatment option for patients suffering from persistent hypertension. The procedure involves a minimally invasive, investigational approach to address hypertension that remains unresponsive to medication. For example, in May 2024, the US-based government agency, Centers for Disease Control and Prevention, reported that 685,875 deaths in the United States in 2022, were either directly or indirectly related to high blood pressure. Consequently, the escalating prevalence of hypertension is set to foster the growth of the renal denervation devices market.

What key areas define the segmentation of the global renal denervation devices Market?

The renal denervation devices market covered in this report is segmented –

1) By Product: Simplicity Renal Denervation System, EnligHTN, Vessix Renal Denervation System, Iberis Renal Sympathetic Denervation System, Paradise Renal Denervation System, Other Products

2) By Technology: Radio Frequency Ablation, Ultrasound Energy-Based RDN, Brachytherapy, Chemical Ablation, Other Technologies

3) By End-Users: Hospitals, Cardiovascular research centre, Other End-Users

Subsegments:

1) By Simplicity Renal Denervation System: Catheter System, Accessories

2) By EnligHTN: Catheter System, Generator, Accessories

3) By Vessix Renal Denervation System: Balloon Catheter, Generator, Accessories

4) By Iberis Renal Sympathetic Denervation System: Catheter System, Accessories

5) By Paradise Renal Denervation System: Catheter System, Accessories

6) By Other Products: Emerging Technologies, Alternative Devices

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10631&type=smp

What are the top market players propelling the growth of the renal denervation devices industry?

Major companies operating in the renal denervation devices market include Medtronic PLC, ReCor Medical Inc., Boston Scientific Corporation, Abbott Laboratories, Cordis Corporation, Terumo Corporation, Kona Medical Inc., St. Jude Medical LLC, Johnson & Johnson, Mercator MedSystems Inc., Symple Surgical Inc., Ablative Solutions Inc., Cardiosonic Ltd., Renal Dynamics Ltd., Vesalio LLC, Atricure Inc., Biosense Webster Inc., Biotronik SE & Co. KG, Cook Medical LLC, Hansen Medical Inc., Merit Medical Systems Inc., AngioDynamics Inc., Covidien Ltd., Volcano Corporation, Edwards Lifesciences Corporation, InnoVein Inc., Teleflex Incorporated, Medinol Ltd., Oscor Inc., Balton Sp. z o.o.

What are the key trends shaping the future of the renal denervation devices market?

Key players in the renal denervation devices market are prioritizing the development of ultrasound renal denervation (uRDN) as a means to increase the effectiveness of treatment, minimize procedure-related complications, and offer a non-invasive alternative to existing renal denervation techniques. The uRDN enhances renal denervation devices by allowing accurate and non-invasive energy transmission to the renal nerves, which results in efficient blood pressure reduction while keeping the surrounding tissues safe, and improves patient safety and comfort during the procedure. For example, in November 2023, Recor Medical Inc., a medical technology firm based in the US, introduced the Paradise uRDN system. This innovative ultrasound renal denervation device is designed to manage hypertension in patients whose blood pressure remained high despite standard lifestyle alterations and medications. The system comes with a hydrocooling feature that safeguards the renal artery during treatment, signifying a major breakthrough in the renal denervation devices market. It provides a non-drug approach to control resistant hypertension, therefore broadening treatment options for patients.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10631

What regions are dominating the renal denervation devices market growth?

Europe was the largest region in the renal denervation devices market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global renal denervation devices market report during the forecast period. The regions covered in the renal denervation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

CRM Software Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/crm-software-global-market-report

Augmented Reality Software Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/augmented-reality-software-global-market-report

Collaboration Software Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/collaboration-software-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: